1. Home
  2. SELX vs MRKR Comparison

SELX vs MRKR Comparison

Compare SELX & MRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SELX

Semilux International Ltd. Ordinary Shares

HOLD

Current Price

$0.30

Market Cap

24.0M

Sector

N/A

ML Signal

HOLD

Logo Marker Therapeutics Inc.

MRKR

Marker Therapeutics Inc.

HOLD

Current Price

$1.27

Market Cap

23.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SELX
MRKR
Founded
2021
1999
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.0M
23.0M
IPO Year
2023
2010

Fundamental Metrics

Financial Performance
Metric
SELX
MRKR
Price
$0.30
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$11.25
AVG Volume (30 Days)
11.4K
116.3K
Earning Date
05-08-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.61
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$621.68
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.81
52 Week High
$1.85
$4.07

Technical Indicators

Market Signals
Indicator
SELX
MRKR
Relative Strength Index (RSI) 25.32 39.16
Support Level N/A $0.83
Resistance Level $1.04 $1.44
Average True Range (ATR) 0.05 0.10
MACD -0.01 0.00
Stochastic Oscillator 7.34 28.75

Price Performance

Historical Comparison
SELX
MRKR

About SELX Semilux International Ltd. Ordinary Shares

Semilux International Ltd is a company that operates through its subsidiaries which is an optical and 3D sensing technology company that is involved in the customization, design and supply of optical components and integrated chip for various industries including autonomous driving, intelligent lighting, as well as unmanned aerial vehicles. In collaboration with its clients, TCO conceptualizes and produces high precision optics and sensing modules that are specifically customized to clients' needs for ease of integration in overall design and production. Applications for TCO's products include automotive laser headlight systems, adaptive driving beams (ADB) as well as light detection and autonomous driving systems (LiDAR).

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

Share on Social Networks: